vs
Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and Marathon Bancorp, Inc. (MBBC). Click either name above to swap in a different company.
Marathon Bancorp, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.6M, roughly 1.4× bioAffinity Technologies, Inc.). Marathon Bancorp, Inc. runs the higher net margin — 22.3% vs -197.0%, a 219.3% gap on every dollar of revenue. On growth, Marathon Bancorp, Inc. posted the faster year-over-year revenue change (41.7% vs -27.8%). Marathon Bancorp, Inc. produced more free cash flow last quarter ($1.4M vs $-2.6M). Over the past eight quarters, Marathon Bancorp, Inc.'s revenue compounded faster (20.3% CAGR vs -18.6%).
bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.
Marathon Bancorp, Inc. is a Maryland-based financial holding company that primarily operates through its community bank subsidiary. It offers a full range of retail and commercial banking products including deposit accounts, consumer loans, commercial mortgages, and small business financing, serving individual and small-to-medium enterprise customers across local markets in Maryland.
BIAF vs MBBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $1.6M | $2.2M |
| Net Profit | $-3.1M | $501.4K |
| Gross Margin | — | — |
| Operating Margin | -196.9% | 26.2% |
| Net Margin | -197.0% | 22.3% |
| Revenue YoY | -27.8% | 41.7% |
| Net Profit YoY | -5.7% | 880.7% |
| EPS (diluted) | $-3.59 | $0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | $2.2M | ||
| Q3 25 | $1.4M | $2.1M | ||
| Q2 25 | $1.3M | $1.9M | ||
| Q1 25 | $1.9M | $1.7M | ||
| Q4 24 | $2.2M | $1.6M | ||
| Q3 24 | $2.4M | $1.6M | ||
| Q2 24 | $2.4M | $1.6M | ||
| Q1 24 | $2.4M | $1.6M |
| Q4 25 | $-3.1M | $501.4K | ||
| Q3 25 | $-5.1M | $444.3K | ||
| Q2 25 | $-4.1M | $-332.0K | ||
| Q1 25 | $-2.7M | $148.4K | ||
| Q4 24 | $-3.0M | $51.1K | ||
| Q3 24 | $-2.0M | $174.9K | ||
| Q2 24 | $-2.1M | $85.8K | ||
| Q1 24 | $-2.0M | $-631.1K |
| Q4 25 | -196.9% | 26.2% | ||
| Q3 25 | -158.6% | 25.5% | ||
| Q2 25 | -198.2% | -25.7% | ||
| Q1 25 | -141.7% | 11.6% | ||
| Q4 24 | -133.5% | 3.3% | ||
| Q3 24 | -84.0% | 13.4% | ||
| Q2 24 | -87.1% | 4.1% | ||
| Q1 24 | -80.8% | -53.7% |
| Q4 25 | -197.0% | 22.3% | ||
| Q3 25 | -349.3% | 20.7% | ||
| Q2 25 | -319.9% | -18.9% | ||
| Q1 25 | -143.5% | 8.9% | ||
| Q4 24 | -134.4% | 3.2% | ||
| Q3 24 | -85.1% | 10.8% | ||
| Q2 24 | -88.0% | 6.2% | ||
| Q1 24 | -81.5% | -40.7% |
| Q4 25 | $-3.59 | $0.19 | ||
| Q3 25 | $-4.74 | $0.17 | ||
| Q2 25 | $-0.17 | $-0.13 | ||
| Q1 25 | $-0.16 | $0.07 | ||
| Q4 24 | $-17.27 | $0.02 | ||
| Q3 24 | $-4.84 | $0.06 | ||
| Q2 24 | $-0.19 | $0.07 | ||
| Q1 24 | $-0.20 | $-0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $46.9M |
| Total Assets | $11.0M | $248.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | — | ||
| Q3 25 | $7.7M | — | ||
| Q2 25 | $802.8K | — | ||
| Q1 25 | $444.7K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $756.6K | — | ||
| Q2 24 | $801.3K | — | ||
| Q1 24 | $2.5M | — |
| Q4 25 | $7.3M | $46.9M | ||
| Q3 25 | $8.9M | $46.3M | ||
| Q2 25 | $-2.1M | $45.7M | ||
| Q1 25 | $1.4M | $32.0M | ||
| Q4 24 | $2.6M | $31.7M | ||
| Q3 24 | $3.1M | $31.6M | ||
| Q2 24 | $3.4M | $31.3M | ||
| Q1 24 | $5.3M | $31.4M |
| Q4 25 | $11.0M | $248.0M | ||
| Q3 25 | $11.5M | $246.0M | ||
| Q2 25 | $4.8M | $238.8M | ||
| Q1 25 | $5.5M | $236.8M | ||
| Q4 24 | $6.5M | $217.9M | ||
| Q3 24 | $6.6M | $216.5M | ||
| Q2 24 | $6.7M | $219.3M | ||
| Q1 24 | $8.0M | $225.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-2.6M | $1.4M |
| Free Cash FlowOCF − Capex | $-2.6M | $1.4M |
| FCF MarginFCF / Revenue | -160.7% | 62.3% |
| Capex IntensityCapex / Revenue | 0.0% | 0.6% |
| Cash ConversionOCF / Net Profit | — | 2.82× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.4M | $3.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.6M | $1.4M | ||
| Q3 25 | $-2.5M | $464.0K | ||
| Q2 25 | $-2.6M | $1.4M | ||
| Q1 25 | $-1.6M | $849.0K | ||
| Q4 24 | $-1.7M | $113.6K | ||
| Q3 24 | $-1.7M | $945.2K | ||
| Q2 24 | $-1.5M | $416.6K | ||
| Q1 24 | $-2.3M | $-802.1K |
| Q4 25 | $-2.6M | $1.4M | ||
| Q3 25 | $-2.5M | $456.6K | ||
| Q2 25 | $-2.7M | $1.3M | ||
| Q1 25 | $-1.7M | $773.2K | ||
| Q4 24 | $-1.7M | $105.0K | ||
| Q3 24 | $-1.7M | $921.6K | ||
| Q2 24 | $-1.6M | $-1.8M | ||
| Q1 24 | $-2.4M | $-1.1M |
| Q4 25 | -160.7% | 62.3% | ||
| Q3 25 | -171.8% | 21.3% | ||
| Q2 25 | -209.6% | 66.0% | ||
| Q1 25 | -91.3% | 46.3% | ||
| Q4 24 | -76.0% | 6.6% | ||
| Q3 24 | -73.1% | 57.1% | ||
| Q2 24 | -65.1% | -118.5% | ||
| Q1 24 | -99.2% | -67.9% |
| Q4 25 | 0.0% | 0.6% | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 1.1% | 9.3% | ||
| Q1 25 | 2.7% | 4.5% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.4% | 1.5% | ||
| Q2 24 | 1.2% | 145.2% | ||
| Q1 24 | 1.7% | 16.2% |
| Q4 25 | — | 2.82× | ||
| Q3 25 | — | 1.04× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.72× | ||
| Q4 24 | — | 2.22× | ||
| Q3 24 | — | 5.40× | ||
| Q2 24 | — | 4.85× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.